Inactive Instrument

Other languages 4d Pharma PLC London S.E.

Equities

GB00BJL5BR07

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

4D Pharma shares cancelled from trading on London's AIM	23-02-15
4D pharma Cancels Trading on London's AIM	23-02-15
TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil	23-02-03
4D pharma plc Updates Results from Renal Cell Carcinoma Cohort	23-02-02
UK shareholder meetings calendar - next 7 days	23-01-09
4D Pharma seeks approval for equity fundraise to lift suspension	22-12-30
4D pharma's Blautix Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics	22-11-18
4D pharma Remains Suspended from Trading on London's AIM	22-09-29
4D Pharma plc Announces Delay in Publication of Interim Results for the Six Months to 30 June 2022	22-09-29
4D pharma plc Announces Publication of Preclinical Research Showing Live Biotherapeutic MRx0006 Efficacy in Animal Model of Autism Spectrum Disorder	22-08-24
4D Pharma plc Is Temporarily Pausing Recruitment into Ongoing Clinical Trials	22-07-05
4D Pharma Temporarily Halts Patient Enrollment In Clinical Trials For Cancer, Asthma, Parkinson's Disease Drugs	22-07-04
4D Pharma Receives Notice Of Delisting From Nasdaq	22-06-29
4D pharma Plans Phase 2 Trial for Metastatic Urothelial Carcinoma Maintenance Therapy	22-05-27
4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology Annual Meeting	22-05-26
European ADRs Move Higher in Tuesday Trading	22-05-17
4D pharma plc Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31
4D pharma plc Auditor Raises 'Going Concern' Doubt	22-03-30
Sector Update: Health Care Stocks Sputtering Ahead at Wednesday Close	22-03-23
Sector Update: Health Care Stocks Retreating Wednesday Afternoon	22-03-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages 4d Pharma PLC London S.E.

Equities

GB00BJL5BR07

Other languages

Filters